Home
>
National Drug Code (NDC)
>
Precose
Precose - 50419-863-51 - (Acarbose)
Drug Information of Precose
| Product NDC: | 50419-863 |
| Proprietary Name: | Precose |
| Non Proprietary Name: | Acarbose |
| Active Ingredient(s): | 25 mg/1 & nbsp; Acarbose |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Precose
| Product NDC: | 50419-863 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020482 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080130 |
Package Information of Precose
| Package NDC: | 50419-863-51 |
| Package Description: | 100 TABLET in 1 BOTTLE (50419-863-51) |
NDC Information of Precose
| NDC Code | 50419-863-51 |
| Proprietary Name | Precose |
| Package Description | 100 TABLET in 1 BOTTLE (50419-863-51) |
| Product NDC | 50419-863 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Acarbose |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20080130 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | ACARBOSE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC] |
